A U.S. jury concluded that one of the world’s most commonly used weed killers played a crucial role to cause a man’s cancer. Monsanto (now Bayer) had strongly denied accepting the claims that its weed killer product was carcinogenic. But the jury in San Francisco ruled that it contributed to causing cancer in Edwin Hardeman. The 70-year-old Californian man sprayed around 6,000 gallons of weed killer over the past three decades. He told jurors the spray regularly got on his skin before he was diagnosed with non-Hodgkin’s lymphoma in 2015. Mr. Edwin has undergone six rounds of chemotherapy to fight against the disease.
The judge supervising the case dived the verdict into two parts. On Tuesday, it was the first step in the hearing. In this verdict, the jury members judged in favor of Mr. Edwin. They found that exposure to the weed killer was a crucial factor in the evolution of his cancer. The court case will now move to the second phase. During this second verdict, the jury will consider whether the company knew about the harmful effects of its product on the user. Besides, the jurors will look at whether the manufacturer knowingly hides those facts from its users. Although, it is not the first time Monsanto is facing a court case. Last year, in August, another American, DeWayne ‘Lee’ Johnson, first filed the lawsuit. The fatally ill man batting for cancer took the pharmaceutical company to court.
At the time the jury awarded Johnson nearly $290 million in damages. Mr. Edwin’s hearing is before another judge, but maybe more important. Currently, Vince Chhabria, U.S. Judge, is supervising many cased of Roundup and has considered Edwin’s case along with two others. In the future, the result of those verdicts can assist lawyers in choosing whether to carry on or settle the matter. The second phase of the case starts on Wednesday. During this one, Mr. Edwin’s lawyers are expected to offer proof reportedly showing manufacturer’s practice to hold researchers, lawmakers and the public regarding its product safety. On the other and, the company says it is confident the evidence in the second hearing will reveal that Monsanto’s behavior has been proper. The company denies taking responsibility for Mr. Edwin’s cancer.